These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 22286140

  • 21. Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis.
    Fismen S, Hedberg A, Fenton KA, Jacobsen S, Krarup E, Kamper AL, Rekvig OP, Mortensen ES.
    Lupus; 2009 Jun; 18(7):597-607. PubMed ID: 19433459
    [Abstract] [Full Text] [Related]

  • 22. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
    Altmann A, Markert A, Askoxylakis V, Schöning T, Jesenofsky R, Eisenhut M, Haberkorn U.
    J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
    [Abstract] [Full Text] [Related]

  • 23. Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis.
    Polzer K, Neubert K, Meister S, Frey B, Baum W, Distler JH, Gückel E, Schett G, Voll RE, Zwerina J.
    Arthritis Rheum; 2011 Mar; 63(3):670-80. PubMed ID: 21360496
    [Abstract] [Full Text] [Related]

  • 24. Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice.
    Lee H, Kim H, Lee G, Chung HS, Bae H.
    Br J Nutr; 2013 Jul 14; 110(1):69-76. PubMed ID: 23181951
    [Abstract] [Full Text] [Related]

  • 25. Clinicopathologic correlations in lupus nephritis in Lima, Peru.
    Hurtado A, Asato C, Escudero E, Stromquist CS, Urcia J, Hurtado ME, de La Cruz S, Wener MH, Zavala R, Johnson RJ.
    Nephron; 1999 Jul 14; 83(4):323-30. PubMed ID: 10575294
    [Abstract] [Full Text] [Related]

  • 26. Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells.
    Ichikawa HT, Conley T, Muchamuel T, Jiang J, Lee S, Owen T, Barnard J, Nevarez S, Goldman BI, Kirk CJ, Looney RJ, Anolik JH.
    Arthritis Rheum; 2012 Feb 14; 64(2):493-503. PubMed ID: 21905015
    [Abstract] [Full Text] [Related]

  • 27. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
    Zoja C, Benigni A, Noris M, Corna D, Casiraghi F, Pagnoncelli M, Rottoli D, Abbate M, Remuzzi G.
    Kidney Int; 2001 Aug 14; 60(2):653-63. PubMed ID: 11473648
    [Abstract] [Full Text] [Related]

  • 28. Redistribution of glomerular dipeptidyl peptidase type IV in experimental lupus nephritis. Demonstration of decreased enzyme activity at the ultrastructural level.
    van Leer EH, Bruijn JA, Prins FA, Hoedemaeker PJ, de Heer E.
    Lab Invest; 1993 May 14; 68(5):550-6. PubMed ID: 8098785
    [Abstract] [Full Text] [Related]

  • 29. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
    Nowis D, McConnell EJ, Dierlam L, Palamarchuk A, Lass A, Wójcik C.
    Int J Cancer; 2007 Jul 15; 121(2):431-41. PubMed ID: 17373661
    [Abstract] [Full Text] [Related]

  • 30. Early treatment with glucocorticoids or cyclophosphamide retains the slit diaphragm proteins nephrin and podocin in experimental lupus nephritis.
    Moysiadis DK, Perysinaki GS, Bertsias G, Stratakis S, Kyriacou K, Nakopoulou L, Boumpas DT, Daphnis E.
    Lupus; 2012 Oct 15; 21(11):1196-207. PubMed ID: 22767414
    [Abstract] [Full Text] [Related]

  • 31. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice.
    Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, Ohno M, Funauchi M, Kanamaru A.
    J Immunol; 2003 Jun 01; 170(11):5793-8. PubMed ID: 12759464
    [Abstract] [Full Text] [Related]

  • 32. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
    Zykova SN, Seredkina N, Benjaminsen J, Rekvig OP.
    Arthritis Rheum; 2008 Mar 01; 58(3):813-25. PubMed ID: 18311834
    [Abstract] [Full Text] [Related]

  • 33. Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress.
    Kawaguchi T, Miyazawa K, Moriya S, Ohtomo T, Che XF, Naito M, Itoh M, Tomoda A.
    Int J Oncol; 2011 Mar 01; 38(3):643-54. PubMed ID: 21174067
    [Abstract] [Full Text] [Related]

  • 34. Accelerated Glomerular Cell Senescence in Experimental Lupus Nephritis.
    Yang C, Xue J, An N, Huang XJ, Wu ZH, Ye L, Li ZH, Wang SJ, Pan QJ, Liang D, Liu HF.
    Med Sci Monit; 2018 Sep 28; 24():6882-6891. PubMed ID: 30265659
    [Abstract] [Full Text] [Related]

  • 35. The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.
    Alexander T, Sarfert R, Klotsche J, Kühl AA, Rubbert-Roth A, Lorenz HM, Rech J, Hoyer BF, Cheng Q, Waka A, Taddeo A, Wiesener M, Schett G, Burmester GR, Radbruch A, Hiepe F, Voll RE.
    Ann Rheum Dis; 2015 Jul 28; 74(7):1474-8. PubMed ID: 25710470
    [Abstract] [Full Text] [Related]

  • 36. Sodium 4-phenylbutyrate treatment protects against renal injury in NZBWF1 mice.
    Bonnemaison ML, Marks-Nelson ES, Boesen EI.
    Clin Sci (Lond); 2019 Jan 31; 133(2):167-180. PubMed ID: 30617186
    [Abstract] [Full Text] [Related]

  • 37. Quantitative studies of immunoglobulin deposition in the kidney, glomerular cell proliferation and glomerulosclerosis in NZB/NZW F1 hybrid mice.
    Hurd ER, Ziff M.
    Clin Exp Immunol; 1977 Feb 31; 27(2):261-8. PubMed ID: 300312
    [Abstract] [Full Text] [Related]

  • 38. Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus.
    Benigni A, Caroli C, Longaretti L, Gagliardini E, Zoja C, Galbusera M, Moioli D, Romagnani P, Tincani A, Andreoli L, Remuzzi G.
    Arthritis Rheum; 2007 May 31; 56(5):1569-78. PubMed ID: 17469139
    [Abstract] [Full Text] [Related]

  • 39. Different effects of bortezomib on the expressions of various protein kinase C isoenzymes in T cells of patients with systemic lupus erythematosus and in Jurkat cells.
    Griger Z, Tóth BI, Baráth S, Gyetvai Á, Kovács I, Tarr T, Bíró T, Zeher M, Sipka S.
    Scand J Immunol; 2012 Feb 31; 75(2):243-8. PubMed ID: 21988336
    [Abstract] [Full Text] [Related]

  • 40. Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice.
    Khodadadi L, Cheng Q, Alexander T, Sercan-Alp Ö, Klotsche J, Radbruch A, Hiepe F, Hoyer BF, Taddeo A.
    PLoS One; 2015 Feb 31; 10(8):e0135081. PubMed ID: 26252021
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.